GlassScriptPhysician profile
Ann L Clements
NPI 1336259852
$13,663.80
in general payments reported to CMS, 2019-2025
35 companies · $3,704 in 2025
The $3,704 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,390 · 2022: $1,807 · 2023: $2,527 · 2024: $3,236 · 2025: $3,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,212 · Education: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,212.30 |
| Education | $254.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,100.33 | 2021-2025 | |
| Janssen Biotech, INC. | $1,246.09 | 2021-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $1,070.09 | 2021-2025 | Ilumya, Winlevi, Absorica Ld |
| Galderma Laboratories, L.P. | $957.66 | 2021-2025 | Nemluvio |
| Dermavant Sciences, INC. | $938.49 | 2022-2024 | Vtama |
| Amgen INC. | $903.53 | 2021-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $849.77 | 2021-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $747.12 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $634.98 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $608.70 | 2022-2025 | Sotyktu |
| Ucb, INC. | $407.26 | 2021-2025 | Bimzelx, Cimzia |
| Leo Pharma INC. | $395.81 | 2021-2025 | Adbry |
| Incyte Corporation | $387.54 | 2021-2025 | Opzelura |
| Revance Therapeutics, INC. | $342.51 | 2024 | Daxxify |
| Lilly USA, LLC | $308.86 | 2021-2025 | Taltz, Ebglyss, Olumiant |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $302.13 | 2025 | Sofdra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $264.55 | 2021-2025 | Jublia, Cabtreo |
| Arcutis Biotherapeutics, INC. | $251.51 | 2023-2025 | Zoryve |
| Pfizer INC. | $226.77 | 2021-2025 | |
| Allergan, INC. | $185.26 | 2021-2022 | |
| Genentech USA, INC. | $151.88 | 2021 | |
| Vyne Pharmaceuticals INC. | $88.72 | 2021 | |
| Almirall LLC | $40.13 | 2021-2025 | Klisyri |
| Mayne Pharma Commercial LLC | $36.16 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.65 | 2025 | Spevigo |
| Journey Medical Corporation | $26.73 | 2022 | |
| Paratek Pharmaceuticals, INC. | $24.02 | 2021 | |
| Lnhc, INC | $22.01 | 2025 | Zelsuvmi |
| Biofrontera INC. | $21.39 | 2025 | Ameluz |
| Sanofi-Aventis U.S. LLC | $19.69 | 2021 | |
| Sandoz INC. | $17.47 | 2021 | |
| Dermira, INC. | $17.43 | 2021 | |
| Verrica Pharmaceuticals INC. | $15.74 | 2024 | Ycanth |
| Helsinn Therapeutics (U.S.), INC. | $12.64 | 2021 | |
| Organon LLC | $12.18 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Clements listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.